机译:新的欧洲批准:Polatuzumab vedotin 与利妥昔单抗、环磷酰胺、多柔比星和泼尼松相关,用于治疗既往未经治疗的弥漫性大 B 细胞淋巴瘤
CHU Clermont Ferrand,CHU Clermont Ferrand;
机译:Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell Lymphoma
机译:A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
机译:Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma.
机译:多相研究Polatuzumab Vedotin + Bendamustine + Rituximab在复发/难治性弥漫性大B细胞淋巴瘤中
机译:Interleukin-10 promoter single nucleotide polymorphism in non-Hodgkin's lymphoma and diffuse large B-cell lymphoma.